Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This indicates a minor update to the page.
    Difference
    0.0%
    Check dated 2026-03-06T20:02:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Results posted for NCT05681481 BALLAD+ open-label extension, with detailed safety and efficacy outcomes including AEs/SAEs/AESIs, discontinuations due to safety, relapse and remission metrics (CRoff/PRoff, CRmin, sustained remission, BPDAI, IGA-BP, Itch NRS) and time points up to 56 weeks. The page also includes links to the Study Protocol and SAP.
    Difference
    5%
    Check dated 2026-02-27T18:25:58.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A minor version update from v3.4.1 to v3.4.2 was applied to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:09:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T22:25:20.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page; no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T05:07:36.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added Results Submitted and Locations sections to the study page, including state-level site listings (Arizona, California, Florida, Michigan, Missouri, Ohio). Updated to Revision: v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T19:58:12.000Z thumbnail image

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.